Anti-ERBB1/EGFR/HER1 Antibody (Zalutumumab)
Catalog No.
F1427
Anti-ERBB1/EGFR/HER1 Antibody (Zalutumumab)
Featured Products
Zalutumumab is a high-affinity, pure human IgG1 monoclonal antibody that targets EGFR. Zalutumumab binds to domain III of the epidermal growth factor receptor and exerts its effects by blocking the binding of epidermal growth factor and interfering with the receptor's active conformation. The EC50 values of zalutumumab for IgG and its Fab fragment are 7 and 19 nM, respectively. Zalutumumab can be used in cancer research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.52 kDa
Dry ice
667901-13-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
HuMax-EGFR, 2F8
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P00533
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human EGFR His at 2 ug/mL can bind Anti-ERBB1/EGFR/HER1 Antibody (Zalutumumab)
ERBB1 / EGFR / HER1
Please avoid freeze-thaw cycles.